Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Rivastigmine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,777Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Luye Pharma Files NDA for Rivastigmine Patch in Japan for AD
    Luye Pharma Files NDA for Rivastigmine Patch in Japan for AD

    06 Jun 2024

    // PRESS RELEASE

    https://www.luye.cn/lvye_en/view.php?id=2250

    PRESS RELEASE
    06 Jun 2024
    Share Share
    Luye Pharma partners with Korea-based Myung In Pharm
    Luye Pharma partners with Korea-based Myung In Pharm

    07 Feb 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/23688/chinas-luye-pharma-partners-with-korea-based-myung-in-pharm-to-improve-alzheimers-related-dementia-treatment.html

    BIOSPECTRUM ASIA
    07 Feb 2024
    Share Share
    Novartis' Prometax (rivastigmine) Receives Approval in Europe
    Novartis' Prometax (rivastigmine) Receives Approval in Europe

    08 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/prometax#overview-section

    EMA
    08 Jun 2023
    Share Share
    Luye Pharma's Rivastigmine Transdermal Patch Receives Market Approval in China
    Luye Pharma's Rivastigmine Transdermal Patch Receives Market Approval in China

    08 Jun 2020

    // PRESS RELEASE

    https://www.luye.cn/lvye_en/view.php?id=1837

    PRESS RELEASE
    08 Jun 2020
    Share Share
    People often skip neurological meds when out-of-pocket costs rise
    People often skip neurological meds when out-of-pocket costs rise

    20 Feb 2020

    // Linda Carroll REUTERS

    https://www.reuters.com/article/us-health-neurology-drug-costs/people-often-skip-neurological-meds-when-out-of-pocket-costs-rise-idUSKBN20D2QG?feedType=RSS&feedName=healthNews

    Linda Carroll REUTERS
    20 Feb 2020
    Share Share
    Zydus Noveltech's Generic Rivastigmine Receives Approval in US
    Zydus Noveltech's Generic Rivastigmine Receives Approval in US

    06 Mar 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206318

    FDA
    06 Mar 2019
    Share Share